Breaking Stories

Pfizer submits data to FDA for Covid-19 vaccine in younger children

Pfizer and BioNTech on Tuesday submitted initial trial data for their Covid-19 vaccine in children aged 5 to 11 with U.S. regulators for emergency use.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *